Skip to main content

Evogene Ltd.

EVGN
Exchange
Nasdaq
Industry
Agricultural Chemicals
SEC CIK
0001574565

In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Evogene Ltd. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of EVGN: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders4439−5
Shares7.41M6.31M−1.10M (−14.9%)
Value$25.3M$16.7M−$8.67M (−34.2%)

New holders (3)

Institutions that held Evogene Ltd. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to EVGN in Q3 2021
InstitutionSharesValue% of portfolio
Vident Investment Advisory, LLC47,160$125.0K0.00%
Crestwood Advisors Group LLC14,000$37.0K0.00%
Howe & Rusling Inc900$2.00K0.00%

Sold out (8)

Institutions that held Evogene Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of EVGN in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Millennium Management LLC72,673$249.0K
XTX Topco Ltd21,169$72.0K
Walleye Capital LLC18,976$65.0K
Cubist Systematic Strategies, LLC16,633$57.0K
Janney Montgomery Scott LLC11,962$41.0K
American Portfolios Advisors2,250$7.70K
Tower Research Capital LLC (TRC)912$3.00K
FMR LLC1$0